Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33898 | 119 | 34.4 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
157 | 3 | JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY//BIOCHEMICAL RESEARCH METHODS//INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 61558 |
370 | 2 | PROTEOMICS//JOURNAL OF PROTEOME RESEARCH//BIOCHEMICAL RESEARCH METHODS | 17272 |
33898 | 1 | LRG1//LEUCINE RICH ALPHA 2 GLYCOPROTEIN 1//LEUCINE RICH ALPHA 2 GLYCOPROTEIN | 119 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LRG1 | authKW | 1824721 | 7% | 89% | 8 |
2 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN 1 | authKW | 1026406 | 3% | 100% | 4 |
3 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN | authKW | 898099 | 6% | 50% | 7 |
4 | LRG | authKW | 461880 | 3% | 60% | 3 |
5 | 32DCL3G | authKW | 256602 | 1% | 100% | 1 |
6 | A2780 CP CELL | authKW | 256602 | 1% | 100% | 1 |
7 | ADSORPTIVE POLAROGRAPHIC WAVE | authKW | 256602 | 1% | 100% | 1 |
8 | ALLERGIC AIRWAY DISORDER | authKW | 256602 | 1% | 100% | 1 |
9 | ANTI CYTOCHROME C ANTIBODY | authKW | 256602 | 1% | 100% | 1 |
10 | CDSMN QUANTUM DOTS | authKW | 256602 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemical Research Methods | 151 | 13% | 0% | 15 |
2 | Oncology | 80 | 15% | 0% | 18 |
3 | Chemistry, Analytical | 49 | 10% | 0% | 12 |
4 | Cell Biology | 37 | 11% | 0% | 13 |
5 | Emergency Medicine | 36 | 3% | 0% | 3 |
6 | Biochemistry & Molecular Biology | 36 | 18% | 0% | 22 |
7 | Immunology | 36 | 10% | 0% | 12 |
8 | Rheumatology | 34 | 3% | 0% | 4 |
9 | Medicine, Research & Experimental | 27 | 7% | 0% | 8 |
10 | Cardiac & Cardiovascular System | 16 | 6% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MASONIC CANC BIOSTAT INFORMAT CORE | 256602 | 1% | 100% | 1 |
2 | NEURO IMMUNE PHARMACOL PERSONALIZED NANO | 256602 | 1% | 100% | 1 |
3 | PATHOPHYSIOLBIOCHEM | 256602 | 1% | 100% | 1 |
4 | PATHOPHYSIOLGASTROENTEROL UNIT | 256602 | 1% | 100% | 1 |
5 | PROT BIOINFORMAT PROJECT | 256602 | 1% | 100% | 1 |
6 | REN JI HOSP MEDMINIST HLTHSTATE KEY ONCOGEN | 256602 | 1% | 100% | 1 |
7 | SHANGHAI CANC SHANGHAI | 256602 | 1% | 100% | 1 |
8 | IMMUNE SIGNALS | 128300 | 1% | 50% | 1 |
9 | INTEGRATED ADV MED TECHNOL ICAM TECH | 128300 | 1% | 50% | 1 |
10 | METAB DIS PROGRAMME | 128300 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROGRAMMED CELL DEATH | 23326 | 1% | 9% | 1 |
2 | PROTEOME SCIENCE | 1845 | 2% | 0% | 2 |
3 | AMERICAN BIOTECHNOLOGY LABORATORY | 1138 | 1% | 0% | 1 |
4 | CANCER PREVENTION RESEARCH | 836 | 2% | 0% | 2 |
5 | ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS | 686 | 2% | 0% | 2 |
6 | DRUG RESISTANCE UPDATES | 528 | 1% | 0% | 1 |
7 | JOURNAL OF OVARIAN RESEARCH | 520 | 1% | 0% | 1 |
8 | PEZCOLLER FOUNDATION SYMPOSIA | 505 | 2% | 0% | 2 |
9 | JOURNAL OF TRANSLATIONAL MEDICINE | 440 | 2% | 0% | 2 |
10 | CIRCULATION-CARDIOVASCULAR GENETICS | 397 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LRG1 | 1824721 | 7% | 89% | 8 | Search LRG1 | Search LRG1 |
2 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN 1 | 1026406 | 3% | 100% | 4 | Search LEUCINE+RICH+ALPHA+2+GLYCOPROTEIN+1 | Search LEUCINE+RICH+ALPHA+2+GLYCOPROTEIN+1 |
3 | LEUCINE RICH ALPHA 2 GLYCOPROTEIN | 898099 | 6% | 50% | 7 | Search LEUCINE+RICH+ALPHA+2+GLYCOPROTEIN | Search LEUCINE+RICH+ALPHA+2+GLYCOPROTEIN |
4 | LRG | 461880 | 3% | 60% | 3 | Search LRG | Search LRG |
5 | 32DCL3G | 256602 | 1% | 100% | 1 | Search 32DCL3G | Search 32DCL3G |
6 | A2780 CP CELL | 256602 | 1% | 100% | 1 | Search A2780+CP+CELL | Search A2780+CP+CELL |
7 | ADSORPTIVE POLAROGRAPHIC WAVE | 256602 | 1% | 100% | 1 | Search ADSORPTIVE+POLAROGRAPHIC+WAVE | Search ADSORPTIVE+POLAROGRAPHIC+WAVE |
8 | ALLERGIC AIRWAY DISORDER | 256602 | 1% | 100% | 1 | Search ALLERGIC+AIRWAY+DISORDER | Search ALLERGIC+AIRWAY+DISORDER |
9 | ANTI CYTOCHROME C ANTIBODY | 256602 | 1% | 100% | 1 | Search ANTI+CYTOCHROME+C+ANTIBODY | Search ANTI+CYTOCHROME+C+ANTIBODY |
10 | CDSMN QUANTUM DOTS | 256602 | 1% | 100% | 1 | Search CDSMN+QUANTUM+DOTS | Search CDSMN+QUANTUM+DOTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WANG, CH , LI, M , LIU, LL , ZHOU, RY , FU, J , ZHANG, CZ , YUN, JP , (2015) LRG1 EXPRESSION INDICATES UNFAVORABLE CLINICAL OUTCOME IN HEPATOCELLULAR CARCINOMA.ONCOTARGET. VOL. 6. ISSUE 39. P. 42118 -42129 | 16 | 62% | 0 |
2 | WEN, SY , ZHANG, LN , YANG, XM , ZHANG, YL , MA, L , GE, QL , JIANG, SH , ZHU, XL , XU, W , DING, WJ , ET AL (2014) LRG1 IS AN INDEPENDENT PROGNOSTIC FACTOR FOR ENDOMETRIAL CARCINOMA.TUMOR BIOLOGY. VOL. 35. ISSUE 7. P. 7125 -7133 | 14 | 56% | 9 |
3 | FURUKAWA, K , KAWAMOTO, K , EGUCHI, H , TANEMURA, M , TANIDA, T , TOMIMARU, Y , AKITA, H , HAMA, N , WADA, H , KOBAYASHI, S , ET AL (2015) CLINICOPATHOLOGICAL SIGNIFICANCE OF LEUCINE-RICH ALPHA 2-GLYCOPROTEIN-1 IN SERA OF PATIENTS WITH PANCREATIC CANCER.PANCREAS. VOL. 44. ISSUE 1. P. 93 -98 | 13 | 62% | 1 |
4 | ELEFTHERIADIS, T , PISSAS, G , LIAKOPOULOS, V , STEFANIDIS, I , (2016) CYTOCHROME C AS A POTENTIALLY CLINICAL USEFUL MARKER OF MITOCHONDRIA AND CELLULAR DAMAGE.FRONTIERS IN IMMUNOLOGY. VOL. 7. ISSUE . P. - | 15 | 44% | 2 |
5 | ZHANG, JJ , ZHU, LY , FANG, JY , GE, ZZ , LI, XB , (2016) LRG1 MODULATES EPITHELIAL-MESENCHYMAL TRANSITION AND ANGIOGENESIS IN COLORECTAL CANCER VIA HIF-1 ALPHA ACTIVATION.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 35. ISSUE . P. - | 11 | 35% | 6 |
6 | HAO, LJ , XIE, H , ZHANG, B , CHEN, D , WANG, SF , ZHANG, HY , HE, SH , (2016) LRG1 DOWNREGULATION IN ALLERGIC AIRWAY DISORDERS AND ITS EXPRESSION IN PERIPHERAL BLOOD AND TISSUE CELLS.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 14. ISSUE . P. - | 13 | 42% | 0 |
7 | DRUHAN, LJ , LANCE, A , LI, S , PRICE, AE , EMERSON, JT , BAXTER, SA , GERBER, JM , AVALOS, BR , (2017) LEUCINE RICH ALPHA-2 GLYCOPROTEIN: A NOVEL NEUTROPHIL GRANULE PROTEIN AND MODULATOR OF MYELOPOIESIS.PLOS ONE. VOL. 12. ISSUE 1. P. - | 12 | 43% | 0 |
8 | MENG, HM , SONG, YJ , ZHU, JY , LIU, Q , LU, PT , YE, N , ZHANG, Z , PANG, YX , QI, JP , WU, H , (2016) LRG1 PROMOTES ANGIOGENESIS THROUGH UPREGULATING THE TGF-BETA 1 PATHWAY IN ISCHEMIC RAT BRAIN.MOLECULAR MEDICINE REPORTS. VOL. 14. ISSUE 6. P. 5535 -5543 | 13 | 37% | 0 |
9 | ZHANG, YR , LUO, Q , WANG, N , HU, FY , JIN, HJ , GE, TX , WANG, C , QIN, WX , (2015) LRG1 SUPPRESSES THE MIGRATION AND INVASION OF HEPATOCELLULAR CARCINOMA CELLS.MEDICAL ONCOLOGY. VOL. 32. ISSUE 5. P. - | 9 | 45% | 4 |
10 | WEIVODA, S , ANDERSEN, JD , SKOGEN, A , SCHLIEVERT, PM , FONTANA, D , SCHACKER, T , TUITE, P , DUBINSKY, JM , JEMMERSON, R , (2008) ELISA FOR HUMAN SERUM LEUCINE-RICH ALPHA-2-GLYCOPROTEIN-1 EMPLOYING CYTOCHROME C AS THE CAPTURING LIGAND.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 336. ISSUE 1. P. 22-29 | 9 | 50% | 28 |
Classes with closest relation at Level 1 |